Literature DB >> 16455310

Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development.

Nathalie Petit1, Anne Blécon, Christian Denier, Elisabeth Tournier-Lasserve.   

Abstract

Cerebral Cavernous Malformation (CCM) is a disease characterized by capillary-venous lesions mostly located in the central nervous system. It occurs both as a sporadic and hereditary autosomal dominant condition. Three CCM genes have been identified and shown to encode the KRIT1 (CCM1), MGC4607 (CCM2) and PDCD10 (CCM3) proteins whose functions are so far unknown. In an attempt to get some insight into the role of the 3 CCM genes, we used in situ hybridization to conduct a comparative analysis of their expression pattern at several time points during murine embryonic, postnatal and adult stages particularly within the central nervous system. A strong expression of the 3 Ccm genes was detected in the various neuronal cell layers of the brain, cerebellum and spinal cord, from embryonic to adult life. By E14.5 a moderate labelling was observed in the heart, arterial and venous large vessels with all 3 Ccm probes. Ccm2 and Ccm3 mRNAs, but not Ccm1, were clearly detected within meningeal and parenchymal cortical vessels at P8. This expression was no more detected by P19 and in adult murine brain, strongly suggesting a role for these 2 proteins in the intensive angiogenesis process occuring within the central nervous system during this period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455310     DOI: 10.1016/j.modgep.2005.11.001

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  29 in total

Review 1.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

2.  PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival.

Authors:  Chengyi Lin; Shuxia Meng; Tina Zhu; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 3.  Endogenous endothelial cell signaling systems maintain vascular stability.

Authors:  Nyall R London; Kevin J Whitehead; Dean Y Li
Journal:  Angiogenesis       Date:  2009-01-27       Impact factor: 9.596

Review 4.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

5.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

6.  KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

Authors:  Luca Goitre; Fiorella Balzac; Simona Degani; Paolo Degan; Saverio Marchi; Paolo Pinton; Saverio Francesco Retta
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

7.  Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.

Authors:  Yuan Zhu; Kai Zhao; Anja Prinz; Kathy Keyvani; Nicole Lambertz; Ilonka Kreitschmann-Andermahr; Ting Lei; Ulrich Sure
Journal:  Neuro Oncol       Date:  2015-08-08       Impact factor: 12.300

8.  Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.

Authors:  Amy L Akers; Eric Johnson; Gary K Steinberg; Joseph M Zabramski; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

9.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.